Cleared Traditional

K882635 - ELECTRONIC DIGITAL BLOOD PRESSURE MONITOR

K882635 is an FDA 510(k) clearance for ELECTRONIC DIGITAL BLOOD PRESSURE MONITOR, manufactured by Nihon Seimitsu Sokki Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 135-day FDA review.

K882635 · Nihon Seimitsu Sokki Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1988
Decision
135d
Days
Class 2
Risk

K882635 is an FDA 510(k) clearance for the ELECTRONIC DIGITAL BLOOD PRESSURE MONITOR. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Nihon Seimitsu Sokki Co., Ltd. (Shibukawa-Shi, Gunma-Ken, JP). The FDA issued a Cleared decision on November 9, 1988 after a review of 135 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Nihon Seimitsu Sokki Co., Ltd. devices

FDA 510(k) Submission Details - K882635

510(k) Number K882635 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 27, 1988
Decision Date November 09, 1988
Days to Decision 135 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
10d slower than avg
Panel avg: 125d · This submission: 135d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 841
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K882635.
TAKEDA MEDICAL AUTO. DIGITAL BLOOD PRES. MONITOR
K882824 · A&D Engineering, Inc. · Jan 1989
TAKEDA MEDICAL AUTO. DIG. BLOOD PRES. METER W/PRIN
K882825 · A&D Engineering, Inc. · Jan 1989
CARDIOCAP(TM) CM-104 MONITOR
K884955 · Datex Division Instrumentarium Corp. · Dec 1988
POCKET MANOMETER
K880599 · Abbott Laboratories · Oct 1988
MODEL BPS08 BLOOD PRESSURE MODULE
K881155 · Fresenius USA, Inc. · Jul 1988
MODEL 404 ADULT HEART RATE/BLOOD PRESSURE MONITOR
K882188 · Ivy Biomedical Systems, Inc. · Jul 1988